Nielsc Riedemann News Today : Breaking News, Live Updates & Top Stories | Vimarsana

InflaRx Appoints Jan Medina as Head of Investor Relations

InflaRx Appoints Jan Medina as Head of Investor Relations
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

United statesNielsc riedemannRegina lutzKatja arnoldLaurie doyleJan medinaExchange commissionInflarx pharmaceuticals incMc servicesTulane university school of engineeringDrug administrationEuropean medicines agencyInflarx commitment programVice presidentInvestor relationsChief executive officer

InflaRx Announces Initiation of its Commitment Program for GOHIBIC®(vilobelimab) to Help Broaden Access for Eligible Patients

InflaRx to cover costs of GOHIBIC for patients who are treated in line with its Emergency Use Authorization but do not survive. InflaRx is determined to support broader access to GOHIBIC for eligible.

United statesLaurie doyleChristian sandrockRegina lutzNielsc riedemannInflarx gmbKatja arnoldExchange commissionInflarx commitment programCommitment programEuropean medicines agencyInflarx pharmaceuticals incCenters for diseaseUc davis healthMc servicesDrug administration

InflaRx N V (IFRX) Announces Initiation of its Commitment Program for GOHIBIC

InflaRx N V (IFRX) Announces Initiation of its Commitment Program for GOHIBIC
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesNielsc riedemannChristian sandrockInflarx pharmaceuticals incCenters for diseaseDivision viceCommitment programDrug administrationInflarx commitment programUc davis healthDisease controlDivision vice chairInternal medicineCritical careChief executive officerLancet respiratory

InflaRx Reports Third Quarter 2023 Financial Results and Provides Business Update

InflaRx Reports Third Quarter 2023 Financial Results and Provides Business Update
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesNielsc riedemannLaurie doyleRegina lutzThomas taapkenKatja arnoldDrug administrationInflarx pharmaceuticals incDevelopment of vilobelimabGerman ministry of educationMc servicesExchange commissionGerman ministry of healthDevelopment expensesEuropean medicines agencyEuropean union

InflaRx Reports Third Quarter 2023 Financial Results and Provides Business Update

Single ascending dose (SAD) Phase I data confirm best-in-class potential of orally available C5aR inhibitor INF904; multiple ascending dose (MAD) .

United statesThomas taapkenNielsc riedemannRegina lutzLaurie doyleKatja arnoldInflarx stops development of vilobelimabInflarx pharmaceuticals incDevelopment expensesEuropean unionGerman ministry of educationMc servicesEuropean medicines agencyDevelopment of vilobelimabExchange commissionDrug administration